sibutramine has been researched along with Ventricular Fibrillation in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A previously well 51-year-old woman with obesity but no other relevant past medical history or cardiac risk factors was prescribed sibutramine (initial dose 10 mg daily, increased to 15 mg daily after 10 wk)." | 3.74 | Sibutramine-associated QT interval prolongation and cardiac arrest. ( Corallo, CE; Ernest, D; Gershenzon, A; Nagappan, R, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernest, D | 1 |
| Gershenzon, A | 1 |
| Corallo, CE | 1 |
| Nagappan, R | 1 |
1 other study available for sibutramine and Ventricular Fibrillation
| Article | Year |
|---|---|
Sibutramine-associated QT interval prolongation and cardiac arrest.
Topics: Appetite Depressants; Cyclobutanes; Defibrillators, Implantable; Drug Monitoring; Electrocardiograph | 2008 |